Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 611 - 620 of 763 studies

Defining responses to infection and antibiotic treatment using wearable devices

Cancer and neoplasms

TERZO - A multicentre, open-label, Phase 3, randomised controlled trial of duvelisib versus investigator’s choice of gemcitabine or bendamustine in patients with relapsed/refractory nodal T cell lymphoma with T follicular helper (TFH) phenotype (SBI-0145-304) (SBI-0145-304 (TERZO))

Cancer and neoplasms

A Randomized, Open-Label, Multicenter, Phase 3 Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP versus Polatuzumab Vedotin plus R-CHP in Treatment-naive Participants with GCB Subtype of Diffuse Large B-Cell Lymphoma (DLBCL) (MK2140-011 (waveline-011))

Cancer and neoplasms

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered In Combination With Induction And Consolidation Chemotherapy And Administered As Maintenance Therapy In Adult Patients With Newly Diagnosed Flt3-Itd Negative Acute Myeloid Leukemia (QuaNTUM-Wild)

Oral and Gastrointestinal

Prospective non-interventional, phase IV multicentre study to assess the effectiveness, safety and tolerability of elafibranor 80 mg/day in patients with primary biliary cholangitis receiving treatment in a real-world setting. (ELfinity)

Cancer and neoplasms

A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma (BGB-11417-302 (CELESTIAL-RRMCL))

Neurological Reproductive health and childbirth

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with an Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine

A Prospective, Screening Study of Bleeding and Treatment in Participants with Von Willebrand Disease

SAIL Research Database (SAIL)

Cancer and neoplasms

A Phase 1-2 Master Protocol to Study ATTR-01 in Participants with Selected Advanced Solid Tumours (ATTEST)